Skip to content

Experimental study of the intestinal environment improving effect by intake of lactic acid bacteria producing extract

Experimental study of the intestinal environment improving effect by intake of lactic acid bacteria producing extract - Experimental study of the intestinal environment improving effect by intake of lactic acid bacteria producing extract

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000039276
Enrollment
30
Registered
2020-01-28
Start date
2020-02-06
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Adults

Interventions

Intake 10ml of lactic acid bacteria producing extract daily for 4 weeks.

Sponsors

B&S corporation Co., Ltd.
Lead Sponsor
Tokyo Medical and Dental University Healthcare Systems Co., Ltd.
Collaborator

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1.Persons who received a sufficient explanation of the purpose and contents of the exam, have the capacity to consent, applied with free will with sufficient understanding, and agreed to participate with a written document 2.Healthy Japanese women who are 30 years old or more and under 50 years old 3.Persons who have constipation tendencies from the preliminary survey questionnaire 4.The top 30 urinary indoxyl sulfate levels at screening

Exclusion criteria

Exclusion criteria: 1.Persons who have chronic illness 2.Persons who are pregnant, planning or hoping to be pregnant during the study period, breastfeeding 3.Persons who are taking medications that affect the intestinal environment, such as intestinal medicines, laxatives, and antibiotics 4.Persons who are taking dietary fiber or lactic acid bacteria supplements that improve the intestinal environment 5.Persons who are allergic to soy 6.Persons who have participated in other tests within the first month before the start of the test, or those who intend to participate in another exam after consenting to this exam

Design outcomes

Primary

MeasureTime frame
Creatinine-corrected urinary indoxyl sulfate levels 4 weeks after continuous intake

Secondary

MeasureTime frame
Questionnaire(Defection status, physical condition, etc) 4 weeks after continuous intake

Countries

Japan

Contacts

Public ContactMiho Matsumoto

Healthcare Systems Co., Ltd. Sales Planning Department

matsumoto@hc-sys.jp050-3640-3595

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026